 Sean Davis
Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Software | 2 | 2016 | 530 | 0.710 |
Why?
| | Genomics | 4 | 2016 | 635 | 0.490 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2016 | 439 | 0.360 |
Why?
| | Neoplasms | 4 | 2016 | 2097 | 0.330 |
Why?
| | Sarcoma, Synovial | 1 | 2007 | 11 | 0.280 |
Why?
| | DNA Copy Number Variations | 3 | 2016 | 154 | 0.270 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2007 | 179 | 0.250 |
Why?
| | Exome | 3 | 2016 | 200 | 0.240 |
Why?
| | Disease Models, Animal | 3 | 2017 | 3535 | 0.180 |
Why?
| | MicroRNAs | 2 | 2016 | 600 | 0.160 |
Why?
| | Point Mutation | 2 | 2016 | 216 | 0.150 |
Why?
| | Exons | 2 | 2016 | 302 | 0.140 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2017 | 18 | 0.140 |
Why?
| | Receptors, Glucocorticoid | 2 | 2009 | 130 | 0.140 |
Why?
| | Enhancer Elements, Genetic | 2 | 2015 | 151 | 0.140 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2017 | 77 | 0.130 |
Why?
| | Adenomatous Polyps | 1 | 2016 | 8 | 0.130 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2016 | 18 | 0.130 |
Why?
| | Cell Line, Tumor | 8 | 2017 | 2711 | 0.130 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2016 | 31 | 0.130 |
Why?
| | Genetic Variation | 3 | 2015 | 870 | 0.130 |
Why?
| | Stomach Neoplasms | 1 | 2016 | 65 | 0.130 |
Why?
| | NFI Transcription Factors | 1 | 2015 | 5 | 0.130 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 182 | 0.120 |
Why?
| | Comparative Genomic Hybridization | 1 | 2015 | 28 | 0.120 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2014 | 6 | 0.120 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2015 | 67 | 0.120 |
Why?
| | Osteosarcoma | 1 | 2015 | 67 | 0.120 |
Why?
| | Thyroid Carcinoma, Anaplastic | 1 | 2014 | 34 | 0.120 |
Why?
| | DNA Methylation | 2 | 2016 | 495 | 0.110 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2015 | 127 | 0.110 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2013 | 12 | 0.110 |
Why?
| | Leukemia, Hairy Cell | 1 | 2013 | 6 | 0.110 |
Why?
| | Neoplasms, Second Primary | 1 | 2015 | 92 | 0.110 |
Why?
| | Transcription Factors | 3 | 2017 | 1528 | 0.110 |
Why?
| | Mutation Rate | 1 | 2013 | 26 | 0.110 |
Why?
| | Esophageal Neoplasms | 1 | 2017 | 273 | 0.110 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2013 | 72 | 0.110 |
Why?
| | Interferon Regulatory Factors | 1 | 2013 | 31 | 0.110 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2013 | 66 | 0.110 |
Why?
| | Data Mining | 1 | 2014 | 100 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2015 | 194 | 0.110 |
Why?
| | Databases, Nucleic Acid | 1 | 2013 | 31 | 0.110 |
Why?
| | RNA, Messenger | 3 | 2016 | 2553 | 0.100 |
Why?
| | Receptor, ErbB-2 | 1 | 2015 | 300 | 0.100 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 181 | 0.100 |
Why?
| | Thyroid Hormone Receptors beta | 1 | 2012 | 1 | 0.100 |
Why?
| | Chromosomes, Human, X | 1 | 2012 | 60 | 0.100 |
Why?
| | Genome | 1 | 2014 | 271 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2017 | 577 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2017 | 951 | 0.100 |
Why?
| | DNA, Neoplasm | 1 | 2012 | 157 | 0.100 |
Why?
| | Replication Origin | 1 | 2011 | 15 | 0.100 |
Why?
| | Thyroid Neoplasms | 1 | 2014 | 264 | 0.100 |
Why?
| | Osteoblasts | 1 | 2012 | 106 | 0.090 |
Why?
| | Pituitary Gland | 1 | 2012 | 148 | 0.090 |
Why?
| | Genetic Loci | 1 | 2012 | 262 | 0.090 |
Why?
| | Gene Silencing | 1 | 2011 | 171 | 0.090 |
Why?
| | Breast Neoplasms | 2 | 2015 | 1862 | 0.090 |
Why?
| | Wnt Signaling Pathway | 1 | 2012 | 146 | 0.090 |
Why?
| | Computational Biology | 1 | 2014 | 530 | 0.090 |
Why?
| | beta Catenin | 1 | 2012 | 219 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 1143 | 0.090 |
Why?
| | Osteogenesis | 1 | 2012 | 183 | 0.090 |
Why?
| | DNA Replication | 1 | 2011 | 202 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2015 | 1880 | 0.080 |
Why?
| | Genetic Linkage | 3 | 2016 | 294 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2016 | 795 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2015 | 1313 | 0.080 |
Why?
| | Genome, Human | 1 | 2011 | 347 | 0.080 |
Why?
| | Genome-Wide Association Study | 1 | 2015 | 1177 | 0.080 |
Why?
| | Gene Expression Regulation | 4 | 2015 | 2320 | 0.080 |
Why?
| | Response Elements | 1 | 2009 | 82 | 0.080 |
Why?
| | Chromatin | 2 | 2011 | 428 | 0.080 |
Why?
| | Animals | 10 | 2017 | 31709 | 0.070 |
Why?
| | Mice | 8 | 2017 | 14872 | 0.070 |
Why?
| | Myoblasts, Skeletal | 1 | 2007 | 11 | 0.070 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1003 | 0.070 |
Why?
| | Muscular Diseases | 1 | 2007 | 104 | 0.070 |
Why?
| | Humans | 15 | 2017 | 114705 | 0.060 |
Why?
| | Prostatic Neoplasms | 1 | 2012 | 921 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 1 | 2008 | 616 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2015 | 1701 | 0.060 |
Why?
| | Mutation | 2 | 2013 | 3346 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2177 | 0.060 |
Why?
| | Nuclear Proteins | 3 | 2013 | 591 | 0.050 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1518 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2086 | 0.050 |
Why?
| | Recombination, Genetic | 2 | 2012 | 176 | 0.050 |
Why?
| | Cell Movement | 2 | 2015 | 869 | 0.050 |
Why?
| | Base Sequence | 2 | 2014 | 2114 | 0.040 |
Why?
| | ErbB Receptors | 2 | 2017 | 554 | 0.040 |
Why?
| | Apoptosis | 1 | 2008 | 2363 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2013 | 445 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2007 | 1473 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2017 | 181 | 0.040 |
Why?
| | Candidiasis | 1 | 2017 | 51 | 0.030 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 84 | 0.030 |
Why?
| | Mice, SCID | 1 | 2017 | 314 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 92 | 0.030 |
Why?
| | Allelic Imbalance | 1 | 2016 | 7 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2009 | 740 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 2016 | 46 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2016 | 40 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 555 | 0.030 |
Why?
| | DNA-Binding Proteins | 2 | 2013 | 1314 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2017 | 177 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2015 | 43 | 0.030 |
Why?
| | Respiratory Mucosa | 1 | 2017 | 251 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 2015 | 61 | 0.030 |
Why?
| | Janus Kinase 3 | 1 | 2015 | 17 | 0.030 |
Why?
| | Adult Survivors of Child Adverse Events | 1 | 2015 | 10 | 0.030 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2015 | 56 | 0.030 |
Why?
| | p300-CBP Transcription Factors | 1 | 2015 | 15 | 0.030 |
Why?
| | Pedigree | 1 | 2016 | 460 | 0.030 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 39 | 0.030 |
Why?
| | Gene Amplification | 1 | 2015 | 95 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2015 | 245 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 2015 | 101 | 0.030 |
Why?
| | Heterografts | 1 | 2014 | 117 | 0.030 |
Why?
| | Connectin | 1 | 2013 | 30 | 0.030 |
Why?
| | Pyrroles | 1 | 2015 | 181 | 0.030 |
Why?
| | Splicing Factor U2AF | 1 | 2013 | 16 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 301 | 0.030 |
Why?
| | Piperidines | 1 | 2015 | 160 | 0.030 |
Why?
| | Immunoglobulin Variable Region | 1 | 2013 | 72 | 0.030 |
Why?
| | RNA, Untranslated | 1 | 2015 | 113 | 0.030 |
Why?
| | Transcription Factor AP-2 | 1 | 2013 | 81 | 0.030 |
Why?
| | Melanocytes | 1 | 2013 | 55 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 521 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 339 | 0.030 |
Why?
| | Pigmentation | 1 | 2013 | 55 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 442 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2015 | 305 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 523 | 0.030 |
Why?
| | Antineoplastic Agents | 2 | 2014 | 1879 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 309 | 0.030 |
Why?
| | Mice, Nude | 1 | 2014 | 630 | 0.030 |
Why?
| | Ribonucleoproteins | 1 | 2013 | 85 | 0.030 |
Why?
| | Segmental Duplications, Genomic | 1 | 2012 | 7 | 0.030 |
Why?
| | Alleles | 1 | 2015 | 789 | 0.030 |
Why?
| | Transfection | 1 | 2014 | 866 | 0.030 |
Why?
| | Down-Regulation | 1 | 2014 | 594 | 0.030 |
Why?
| | Pharmacogenetics | 1 | 2013 | 149 | 0.020 |
Why?
| | Triiodothyronine | 1 | 2012 | 42 | 0.020 |
Why?
| | Pyrimidines | 1 | 2015 | 376 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1131 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2012 | 271 | 0.020 |
Why?
| | Fanconi Anemia | 1 | 2011 | 9 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2011 | 21 | 0.020 |
Why?
| | Chromosomal Instability | 1 | 2011 | 18 | 0.020 |
Why?
| | Protein Stability | 1 | 2012 | 157 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 723 | 0.020 |
Why?
| | K562 Cells | 1 | 2011 | 73 | 0.020 |
Why?
| | Transcription Initiation Site | 1 | 2011 | 40 | 0.020 |
Why?
| | Autoimmunity | 1 | 2017 | 813 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2011 | 63 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2570 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 959 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2012 | 487 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2012 | 372 | 0.020 |
Why?
| | CpG Islands | 1 | 2011 | 117 | 0.020 |
Why?
| | Prostate | 1 | 2012 | 156 | 0.020 |
Why?
| | Female | 5 | 2016 | 59521 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1760 | 0.020 |
Why?
| | Zebrafish | 1 | 2013 | 412 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 3886 | 0.020 |
Why?
| | Databases, Factual | 1 | 2014 | 1125 | 0.020 |
Why?
| | Autoantigens | 1 | 2012 | 396 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 282 | 0.020 |
Why?
| | DNA Damage | 1 | 2011 | 351 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2785 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 128 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2012 | 529 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2012 | 476 | 0.020 |
Why?
| | Family | 1 | 2012 | 589 | 0.020 |
Why?
| | Tyrphostins | 1 | 2008 | 13 | 0.020 |
Why?
| | Nucleoproteins | 1 | 2008 | 27 | 0.020 |
Why?
| | Genes, erbB-2 | 1 | 2008 | 26 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2015 | 2187 | 0.020 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 26 | 0.020 |
Why?
| | Disease Progression | 1 | 2014 | 2380 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2011 | 551 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2008 | 100 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1569 | 0.020 |
Why?
| | Mesoderm | 1 | 2008 | 138 | 0.020 |
Why?
| | Epithelium | 1 | 2008 | 295 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 337 | 0.020 |
Why?
| | DNA Helicases | 1 | 2008 | 133 | 0.020 |
Why?
| | Quinazolines | 1 | 2008 | 240 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 433 | 0.020 |
Why?
| | RNA Polymerase II | 1 | 2009 | 284 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 993 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2008 | 319 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 4694 | 0.020 |
Why?
| | Proteomics | 1 | 2011 | 836 | 0.020 |
Why?
| | Kinetics | 1 | 2009 | 1551 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 372 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 296 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2008 | 385 | 0.010 |
Why?
| | Histones | 1 | 2008 | 535 | 0.010 |
Why?
| | Protein Binding | 1 | 2008 | 1890 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2637 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 785 | 0.010 |
Why?
| | RNA | 1 | 2008 | 809 | 0.010 |
Why?
| | Signal Transduction | 1 | 2013 | 4516 | 0.010 |
Why?
| | Phenotype | 1 | 2008 | 2797 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 10471 | 0.010 |
Why?
| | Male | 2 | 2016 | 55607 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 6116 | 0.010 |
Why?
| | Middle Aged | 1 | 2015 | 26738 | 0.010 |
Why?
| | Adult | 1 | 2015 | 30553 | 0.010 |
Why?
|
|
Davis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|